Like the flu and COVID, the symptoms of a cold are often coughing, a sore throat, tiredness and sometimes a fever. However, ...
Cases of the respiratory illness are rising in January 2026 across the state, including in the Sacramento area.
Guidelines recommend a single dose of RSV vaccine for older adults, but long-term data on the duration of protection is limited. In this study of U.S. veterans, effectiveness slid from over 80% in the ...
Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company's respiratory ...
Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV numbers were rated "high," joining a total of 18 states rated "high" or "very ...
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...